Skip to main content
Vor Biopharma Inc. logo

Vor Biopharma Inc. — Investor Relations & Filings

Ticker · VOR ISIN · US9290331084 US Professional, scientific and technical activities
Open in API
Filings indexed 406 across all filing types
Latest filing 2022-09-15 Director's Dealing
Country US United States of America
Listing US VOR

About Vor Biopharma Inc.

https://www.vorbio.com/

Vor Biopharma Inc. is a clinical-stage biotechnology company focused on developing treatments for autoimmune diseases. The company is committed to advancing medicines that target the fundamental drivers of autoimmunity, aiming to move beyond symptom control. Its lead candidate, telitacicept, is designed to silence the signals that allow harmful immune cells to survive. The company's objective is to deliver safer, longer-lasting therapies that address the source of autoimmune conditions.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2022-09-15 English
FORM 4 SUBMISSION
Director's Dealing
2022-09-06 English
FORM 4 SUBMISSION
Director's Dealing
2022-09-06 English
10-Q
Interim / Quarterly Report Q2 2022
2022-08-11 English
OWNERSHIP DOCUMENT
Director's Dealing
2022-06-17 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 14, 2022, reporting the submission of matters to a vote of security holders at the company's 2022 Annual Meeting of Stockholders. It details the voting results for director elections and ratification of the independent auditor. The content focuses on official voting results from the Annual Meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4360 characters, which is relatively short but contains substantive voting results, not just an announcement of a report. Therefore, it is not a Report Publication Announcement (RPA). It is not a proxy statement or management report but specifically the voting results. Hence, the correct classification is DVA with high confidence.
2022-06-17 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.